IRIS
OREFICE, GIUSEPPE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.956
AS - Asia 3.288
EU - Europa 2.334
SA - Sud America 410
Continente sconosciuto - Info sul continente non disponibili 150
AF - Africa 93
OC - Oceania 3
Totale 10.234
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.748
SG - Singapore 1.428
RU - Federazione Russa 1.056
VN - Vietnam 662
CN - Cina 592
IT - Italia 430
BR - Brasile 327
HK - Hong Kong 282
DE - Germania 170
CA - Canada 134
FI - Finlandia 125
NL - Olanda 125
FR - Francia 111
GB - Regno Unito 74
IE - Irlanda 64
IN - India 60
JP - Giappone 51
UA - Ucraina 43
MX - Messico 40
AR - Argentina 38
BD - Bangladesh 38
ZA - Sudafrica 31
SE - Svezia 27
IQ - Iraq 25
CI - Costa d'Avorio 23
ES - Italia 19
PH - Filippine 19
TH - Thailandia 19
PL - Polonia 18
AT - Austria 16
KR - Corea 15
TR - Turchia 14
LT - Lituania 13
EC - Ecuador 11
ID - Indonesia 11
PY - Paraguay 10
TW - Taiwan 10
AE - Emirati Arabi Uniti 9
DK - Danimarca 9
EG - Egitto 9
PK - Pakistan 9
BE - Belgio 8
JM - Giamaica 7
KE - Kenya 7
MA - Marocco 7
CO - Colombia 6
EE - Estonia 6
VE - Venezuela 6
CL - Cile 5
IR - Iran 5
AL - Albania 4
LB - Libano 4
SA - Arabia Saudita 4
TT - Trinidad e Tobago 4
CR - Costa Rica 3
GE - Georgia 3
GT - Guatemala 3
JO - Giordania 3
KZ - Kazakistan 3
LY - Libia 3
MK - Macedonia 3
MY - Malesia 3
TN - Tunisia 3
UZ - Uzbekistan 3
XK - ???statistics.table.value.countryCode.XK??? 3
AZ - Azerbaigian 2
BO - Bolivia 2
CH - Svizzera 2
CZ - Repubblica Ceca 2
DO - Repubblica Dominicana 2
HT - Haiti 2
KG - Kirghizistan 2
KH - Cambogia 2
MR - Mauritania 2
NI - Nicaragua 2
NP - Nepal 2
PA - Panama 2
PE - Perù 2
UY - Uruguay 2
AF - Afghanistan, Repubblica islamica di 1
AG - Antigua e Barbuda 1
AI - Anguilla 1
AM - Armenia 1
BB - Barbados 1
BF - Burkina Faso 1
BG - Bulgaria 1
BJ - Benin 1
BZ - Belize 1
CG - Congo 1
DM - Dominica 1
DZ - Algeria 1
EU - Europa 1
GR - Grecia 1
GY - Guiana 1
HR - Croazia 1
HU - Ungheria 1
IL - Israele 1
IS - Islanda 1
KW - Kuwait 1
LC - Santa Lucia 1
Totale 10.070
Salva come PNG Salva come JPEG
Città #
Singapore 625
San Jose 619
Ashburn 501
Hong Kong 264
Moscow 237
Beijing 203
Chandler 202
Ho Chi Minh City 198
Council Bluffs 156
Hanoi 135
Santa Clara 124
Amsterdam 115
Los Angeles 111
Naples 105
Princeton 83
Munich 80
Millbury 75
The Dalles 70
Lauterbourg 67
Dallas 59
Nanjing 57
New York 52
Tokyo 51
Boston 49
São Paulo 47
Ottawa 44
Buffalo 37
Da Nang 35
Jacksonville 33
Toronto 33
Wilmington 32
Napoli 29
Phoenix 28
Orem 27
Des Moines 26
Seattle 26
Rome 25
Denver 24
Turku 24
Brooklyn 23
Haiphong 23
Helsinki 23
Houston 23
Norwalk 23
Redondo Beach 23
Hefei 22
Atlanta 21
Chennai 21
Mexico City 19
Tianjin 17
Montreal 16
Nanchang 16
Warsaw 16
Milan 15
Chicago 14
Columbus 13
Hebei 13
Johannesburg 13
Stockholm 13
Brasília 12
Dong Ket 12
Jiaxing 12
London 12
Mumbai 12
Poplar 12
Rio de Janeiro 11
Augusta 10
Baghdad 10
Carrboro 10
Shenyang 10
Curitiba 9
Miami 9
Thái Bình 9
Brussels 8
Falkenstein 8
Frankfurt am Main 8
Palermo 8
San Francisco 8
Thái Nguyên 8
Washington 8
Ankara 7
Biên Hòa 7
Can Tho 7
Nairobi 7
Bangkok 6
Bari 6
Boardman 6
Catania 6
Charlotte 6
Erbil 6
Guangzhou 6
Hải Dương 6
Las Vegas 6
Manchester 6
Philadelphia 6
Phủ Lý 6
Pune 6
Querétaro 6
Asunción 5
Bắc Giang 5
Totale 5.403
Salva come PNG Salva come JPEG
Nome #
Nuove tecniche di imaging nello studio delle alterazioni perfusionali cerebrali e dei processi di degenerazione neuronale in soggetti affetti da sclerosi multipla e da altre patologie neurologiche degenerative. Associazioni tra marcatori radiologici e polimorfismi genetici di predisposizione e decorso delle malattie neurodegenerative 293
Flunarizine in prophylaxis of childhood migraine. A double-blind, placebo-controlled, crossover study. 237
Immunometabolic profiling of T cells from patients with relapsing-remitting multiple sclerosis reveals an impairment in glycolysis and mitochondrial respiration 186
Atorvastatin combined to interferon to verify the efficacy (ACTIVE) in relapsing-remitting active multiple sclerosis patients: a longitudinal controlled trial of combination therapy. 178
Assessment of neuroactive steroids in cerebrospinal fluid comparing acute relapse and stable disease in relapsing-remitting multiple sclerosis 176
Gender differences in non-motor symptoms in early, drug naïve Parkinson's disease 168
A double-blind cross-over trial of amantadine hydrochloride in Friedreich's ataxia. 167
The effects of mechanical focal vibration on walking impairment in multiple sclerosis patients: A randomized, double-blinded vs placebo study 166
Epileptic seizures in multiple sclerosis: clinical and EEG correlations. 163
Multiple sclerosis and headache co-morbidity. A case-control study 161
The Heterogeneity of Early Parkinson?s Disease: A Cluster Analysis on Newly Diagnosed Untreated Patients 161
Brain atrophy in Relapsing-remitting multiple sclerosis patients treated with interferon-beta and atorvastatin (The ARIANNA study). 160
Inhibition of oligodendrocyte differentiation by immunoglobulin purified from serum of multiple sclerosis patients during relapse 156
Levetiracetam for cerebellar tremor in multiple sclerosis: an open-label pilot tolerability and efficacy study. 155
Grey matter loss in relapsing-remitting multiple sclerosis: a voxel-based morphometry study. 154
Brain tissue volume changes in relapsing-remitting multiple sclerosis: correlation with lesion load. NeuroImage18: 360-366, 2003.. 151
Analisi conoscitiva del grado di aderenza di strutture di riabilitazione alle principali linee guida nazionali nel trattamento di pazienti afasici e disfagici. 151
Upper motor neuron evaluation in multiple sclerosis patients treated with Sativex(®) 151
Brain atrophy and lesion load in a large population of patients with multiple sclerosis 150
The IFN-β 1b effect on Cu Zn superoxide dismutase (SOD1) in peripheral mononuclear blood cells of relapsing-remitting multiple sclerosis patients and in neuroblastoma SK-N-BE cells 149
Pragmatic abilities in multiple sclerosis: The contribution of the temporo-parietal junction 149
Oral Palmitoylethanolamide Treatment Is Associated with Reduced Cutaneous Adverse Effects of Interferon-β1a and Circulating Proinflammatory Cytokines in Relapsing–Remitting Multiple Sclerosis 148
Flunarizine in prophylaxis of childhood migraine. A double-blind, placebo-controlled, crossover study. 144
Long-term clinical experience with weekly interferon beta-1a in relapsing multiple sclerosis 142
Correlation between fatigue and brain atrophy and lesion load in multiple sclerosis patients independent of disability. 139
Age-related risk factors for ischemic stroke in Italian men. 137
Neuropsychological assessment, quantitative MRI and ApoE gene polymorphisms in a series of MS patients treated with IFN beta-1b. 136
Vitamin D in a population of Southern Italy relapsing remitting and secondary progressive multiple sclerosis patients. 136
An open label randomised clinical trial of atorvastatin in combination with IFN beta-1a in active MS patients: 12 months results. 134
Serum levels of insulin-like growth factor-1 and insulin-like growth factor binding protein-3 in relapsing and secondary progressive IFN beta treated MS patients 134
Predictive factors of neutralizing antibodies development in relapsing-remitting multiple sclerosis patients on interferon Beta-1b therapy. 133
Serum levels of insulin like growth factor-1 and insulin like growth factor binding protein-3 in relapsing and secondary progressive multiple sclerosis 133
Communication in Multiple Sclerosis: Pragmatic Deficit and its Relation with Cognition and Social Cognition 133
Successful treatment of paraneoplastic cerebellar degeneration with Rituximab. 129
The use of University of Pennsylvania Smell Identification Test in the diagnosis of Parkinson's disease in Italy. 129
Aerodynamic findings and Voice Handicap Index in Parkinson’s disease 128
Recurrent pulmonary and cerebral thromboembolism in an adult patients following incomplete removal of ventriculoatrial shunt for congenital hydrocephalus. 126
Three primitive reflexes in HIV-1-infected individuals: a possible clinical marker of early central nervous system involvement. 124
Correlation of disease severity and regional brain tissue loss in relapsing-remitting multiple sclerosis: a voxel-based morphometry study in a large population 124
Natalizumab is effective in multiple sclerosis patients switching from other disease modifying therapies in clinical practice. 123
Prognostic value of combined target-organ damage in patients with essential hypertension 123
Do gonadotropins play a role in catamenial epilepsy? | [Le gonadotropine ipofisarie hanno un ruolo nella patogenesi delle crisi catameniali?]. 122
Gender differences in non-motor symptoms in early, drug naive Parkinson's disease 121
Anatomical and functional retinal changes in multiple sclerosis 121
A voxel-based morphometry study of disease severity correlates in relapsing-remitting multiple sclerosis 116
Brain atrophy evolution and lesion load accrual in multiple sclerosis: a 2-year follow-up study 115
Comparative effects of mesoglycan and ticlopidine treatment on some coagulative parameters in patients with previous ischemic stroke: Results of a randomized controlled trial 115
Absence of cerebrospinal fluid oligoclonal bands is associated with delayed disability progression in relapsing-remitting MS patients treated with interferon-beta. 114
Regional GM loss in MS: a comparison between Primary-Progressive and Relapsing-Remitting MS phenotypes. 113
HLA-DRB1*1501 and response to copolymer-1 therapy in relapsing-remitting multiple sclerosis. 112
The management of multiple sclerosis by reference centers in south of Italy: a 2011 survey on health demands and needs in Campania region 112
Switching disease-modifying therapies in multiple sclerosis: follow-up of 108 patients. In MULTIPLE SCLEROSIS (Vol. 11, pp. S159-S159). 338 EUSTON ROAD, LONDON NW1 3BH, ENGLAND: HODDER ARNOLD, HODDER HEADLINE PLC. 112
The results of two multicenter, open-label studies assessing efficacy, tolerability and safety of protiramer, a high molecular weight synthetic copolymeric mixture, in patients with relapsing-remitting multiple sclerosis. 110
Benign intracranial hypertension of obese women. A twenty cases report. 110
Transient global amnesia in a young woman on prolonged treatment with oral contraceptive drugs. 106
Clinical and computerized tomographic study of a case of Schilder's disease. 106
Microalbuminuria predicts the recurrence of cardiovascular events in patients with essential hypertension 106
Is brain atrophy progression in RR-MS slowed by the association off atorvastatin and interferon beta-1a? Preliminary results from an open-label, randomized, clinical study 106
Interferon beta-1a and atorvastatin combination therapy: 12-month results from an open-label, randomized, clinical study. 104
No effect of acetylsalicylic acid on B-thromboglobulin and platelet factor 4 plasma levels in patients with transient ischaemic attacks. 101
Differential effects of three interferon betas on neutralising antibodies in patients with multiple sclerosis: a follow up study in an independent laboratory. 99
Antithrombotic effect of indobufen in an experimental model of arterio-arterial microanastomosis in the rat. 96
B-thromboglobulin and Platelet Factor-4 Measured By A Radioimmunoassay As Indexes of Platelet Activation In Patients With Migraine 95
No effect of cloricromen on some coagulation parameters in patients with ischaemic cerebrovascular disease. 94
Brain tissue volume changes in relapsing-remitting multiple sclerosis: correlation with lesion load. 93
NAbs effect on cognitive, clinical and quantitative MRI outcome measures in RR-MS IFN beta-1b treated patients 92
Safety and tolerability in relapsing-remitting multiple sclerosis patients treated with high-dose subcutaneous interferon-beta by Rebiject autoinject on over a 1-year period: the CoSa study. 91
Idiopathic intracranial hypertension in a patient with thyroid papillary carcinoma 88
Usefulness of the Radioimmunoassay of B-thromboglobulin In Transient Ischemic Attacks 85
No effect of cloricromen on some coagulation parameters in patients with ischaemic cerebrovascular disease. 85
Dati aerodinamici della voce dei soggetti con malattia di Parkinson preliminari al trattamento riabilitativo logopedico 85
Presence of papova-like viral particles in cerebrospinal fluid of AIDS patients with progressive multifocal leukoencephalopathy. An additional test for "in vivo" diagnosis. 84
[The physiopathology of supranuclear structures in oculomotor disorders]. 83
Interferon-beta treatment decreases cholesterol plasma levels in multiple sclerosis patients. 82
No evidence for an effect on brain atrophy rate of atorvastatin add-on to interferon β1b therapy in relapsing-remitting multiple sclerosis (the ARIANNA study) 76
Platelet-function In Childhood Migraine 74
[Fahr syndrome with and without hypoparathyroidism. 2 cases]. 74
Combining beta interferon and atorvastatin may increase disease activity in multiple sclerosis. 73
Spontaneous resolution of Chiari type 1 malformation. A case report and literature review 71
Post-exercise facilitation and depression of motor evoked potentials to transcranial magnetic stimulation: a study in multiple sclerosis 69
Epilepsy and multiple sclerosis: Review of literature and our epilepsy center's experience 69
Natalizumab vs interferon beta 1a inrelapsing-remitting multiple sclerosis: a head-to-head retrospective study. 68
Subcutaneous interferon ?-1a may protect against cognitive impairment in patients with relapsing-remitting multiple sclerosis: 5-year follow-up of the COGIMUS study. 49
Totale 10.234
Salva come PNG Salva come JPEG
Categoria #
all - tutte 33.900
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.900
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022406 0 0 0 2 1 18 1 16 67 48 86 167
2022/2023534 83 36 17 25 70 44 0 39 73 104 26 17
2023/2024504 15 69 134 38 34 45 10 44 5 7 77 26
2024/20252.328 120 87 8 33 74 120 241 153 158 274 848 212
2025/20264.620 496 235 411 516 876 140 730 191 513 337 91 84
2026/2027989 186 154 146 503 0 0 0 0 0 0 0 0
Totale 10.234